ZYME Annual CFF
$81.85 M
-$26.73 M-24.62%
31 December 2023
Summary:
As of January 23, 2025, ZYME annual cash flow from financing activities is $81.85 million, with the most recent change of -$26.73 million (-24.62%) on December 31, 2023. During the last 3 years, it has fallen by -$227.13 million (-73.51%). ZYME annual CFF is now -73.51% below its all-time high of $308.98 million, reached on December 31, 2020.ZYME Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYME Quarterly CFF
-$14.98 M
-$16.03 M-1529.29%
30 September 2024
Summary:
As of January 23, 2025, ZYME quarterly cash flow from financing activities is -$14.98 million, with the most recent change of -$16.03 million (-1529.29%) on September 30, 2024. Over the past year, it has dropped by -$17.10 million (-805.56%). ZYME quarterly CFF is now -104.95% below its all-time high of $302.83 million, reached on March 31, 2020.ZYME Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYME TTM CFF
$38.80 M
-$16.88 M-30.31%
30 September 2024
Summary:
As of January 23, 2025, ZYME TTM cash flow from financing activities is $38.80 million, with the most recent change of -$16.88 million (-30.31%) on September 30, 2024. Over the past year, it has dropped by -$43.43 million (-52.81%). ZYME TTM CFF is now -92.18% below its all-time high of $495.92 million, reached on March 31, 2020.ZYME TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYME Cash From Financing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -24.6% | -805.6% | -52.8% |
3 y3 years | -73.5% | -429.6% | +287.4% |
5 y5 years | -10.5% | -1599.4% | -80.0% |
ZYME Cash From Financing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -24.6% | +921.7% | -113.8% | at low | -66.1% | +2169.2% |
5 y | 5-year | -73.5% | +921.7% | -105.0% | at low | -92.2% | +2169.2% |
alltime | all time | -73.5% | +5298.9% | -105.0% | at low | -92.2% | +2169.2% |
Zymeworks Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$14.98 M(-1529.3%) | $38.80 M(-30.3%) |
June 2024 | - | $1.05 M(-50.6%) | $55.68 M(-32.3%) |
Mar 2024 | - | $2.12 M(-95.8%) | $82.23 M(+0.5%) |
Dec 2023 | $81.85 M(-24.6%) | $50.61 M(+2569.4%) | $81.85 M(+165.2%) |
Sept 2023 | - | $1.90 M(-93.1%) | $30.86 M(+4.3%) |
June 2023 | - | $27.60 M(+1488.1%) | $29.59 M(+1630.5%) |
Mar 2023 | - | $1.74 M(-561.0%) | $1.71 M(-98.4%) |
Dec 2022 | $108.58 M(+1255.4%) | -$377.00 K(-160.0%) | $108.58 M(-1.0%) |
Sept 2022 | - | $628.00 K(-325.1%) | $109.65 M(-3.4%) |
June 2022 | - | -$279.00 K(-100.3%) | $113.56 M(-0.8%) |
Mar 2022 | - | $108.61 M(>+9900.0%) | $114.52 M(+1329.5%) |
Dec 2021 | $8.01 M(-97.4%) | $689.00 K(-84.8%) | $8.01 M(-20.0%) |
Sept 2021 | - | $4.54 M(+577.3%) | $10.02 M(+14.9%) |
June 2021 | - | $671.00 K(-68.1%) | $8.72 M(+5.6%) |
Mar 2021 | - | $2.11 M(-21.8%) | $8.25 M(-97.3%) |
Dec 2020 | $308.98 M | $2.69 M(-17.0%) | $308.98 M(+0.2%) |
Sept 2020 | - | $3.25 M(+1483.9%) | $308.44 M(+0.7%) |
June 2020 | - | $205.00 K(-99.9%) | $306.19 M(-38.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2020 | - | $302.83 M(>+9900.0%) | $495.92 M(+156.1%) |
Dec 2019 | $193.66 M(+111.8%) | $2.16 M(+116.0%) | $193.66 M(+1.2%) |
Sept 2019 | - | $999.00 K(-99.5%) | $191.36 M(+1.0%) |
June 2019 | - | $189.94 M(>+9900.0%) | $189.45 M(+106.2%) |
Mar 2019 | - | $569.00 K(-489.7%) | $91.87 M(+0.5%) |
Dec 2018 | $91.43 M(+83.0%) | -$146.00 K(-83.9%) | $91.43 M(-0.3%) |
Sept 2018 | - | -$905.00 K(-101.0%) | $91.70 M(-0.8%) |
June 2018 | - | $92.35 M(>+9900.0%) | $92.44 M(+84.5%) |
Mar 2018 | - | $131.00 K(+4.8%) | $50.10 M(+0.3%) |
Dec 2017 | $49.95 M(-22.9%) | $125.00 K(-177.2%) | $49.95 M(+2.9%) |
Sept 2017 | - | -$162.00 K(-100.3%) | $48.53 M(+0.1%) |
June 2017 | - | $50.00 M(<-9900.0%) | $48.46 M(+749.2%) |
Mar 2017 | - | -$15.00 K(-98.8%) | $5.71 M(-91.2%) |
Dec 2016 | $64.78 M(+4172.9%) | -$1.29 M(+460.2%) | $64.78 M(-2.0%) |
Sept 2016 | - | -$231.00 K(-103.2%) | $66.07 M(-0.3%) |
June 2016 | - | $7.25 M(-87.7%) | $66.30 M(+12.3%) |
Mar 2016 | - | $59.05 M | $59.05 M |
Dec 2015 | $1.52 M(-96.7%) | - | - |
Dec 2014 | $46.39 M | - | - |
FAQ
- What is Zymeworks annual cash flow from financing activities?
- What is the all time high annual CFF for Zymeworks?
- What is Zymeworks annual CFF year-on-year change?
- What is Zymeworks quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Zymeworks?
- What is Zymeworks quarterly CFF year-on-year change?
- What is Zymeworks TTM cash flow from financing activities?
- What is the all time high TTM CFF for Zymeworks?
- What is Zymeworks TTM CFF year-on-year change?
What is Zymeworks annual cash flow from financing activities?
The current annual CFF of ZYME is $81.85 M
What is the all time high annual CFF for Zymeworks?
Zymeworks all-time high annual cash flow from financing activities is $308.98 M
What is Zymeworks annual CFF year-on-year change?
Over the past year, ZYME annual cash flow from financing activities has changed by -$26.73 M (-24.62%)
What is Zymeworks quarterly cash flow from financing activities?
The current quarterly CFF of ZYME is -$14.98 M
What is the all time high quarterly CFF for Zymeworks?
Zymeworks all-time high quarterly cash flow from financing activities is $302.83 M
What is Zymeworks quarterly CFF year-on-year change?
Over the past year, ZYME quarterly cash flow from financing activities has changed by -$17.10 M (-805.56%)
What is Zymeworks TTM cash flow from financing activities?
The current TTM CFF of ZYME is $38.80 M
What is the all time high TTM CFF for Zymeworks?
Zymeworks all-time high TTM cash flow from financing activities is $495.92 M
What is Zymeworks TTM CFF year-on-year change?
Over the past year, ZYME TTM cash flow from financing activities has changed by -$43.43 M (-52.81%)